Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Epizyme, Inc. | 322,626 | reported | 25 Mar 2021 | tx 33+2,480,527−256,297 |
| Nuvation Bio Inc. | 123,397 | reported | 21 May 2026 | tx 10+1,533,012 |
| ARDELYX, INC. | 41,551 | reported | 18 Jun 2025 | tx 11+446,355 |
| Akari Therapeutics Plc | 30,932 | reported | 16 Dec 2025 | tx 10+5,843,252 |
| TRIMERIS INC | 0 | reported | 22 Jun 2015 | tx 5+85,000−85,000 |
| Neon Therapeutics, Inc. | 0 | reported | 06 May 2020 | tx 4+46,500−46,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Nuvation Bio Inc. | 123,397 | 0.00 USD | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 30,932 | 0.40 USD | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 30,932 | — | derivfirst after silence |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 123,731 | 0.40 USD | deriv |
| 16 Dec 2025 | PURCHASE | Akari Therapeutics Plc | 123,731 | — | deriv |
| 18 Jun 2025 | GRANT_AWARD | ARDELYX, INC. | 41,551 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | ARDELYX, INC. | 54,059 | 0.00 USD | deriv |
| 21 May 2025 | GRANT_AWARD | Nuvation Bio Inc. | 292,983 | 0.00 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 225,000 | 0.00 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 175,000 | 0.00 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 44,642 | 1.12 USD | |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 44,642 | 1.12 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | Akari Therapeutics Plc | 44,642 | 1.12 USD | deriv |
| 17 Sept 2024 | GRANT_AWARD | Akari Therapeutics Plc | 5,000,000 | 0.00 USD | deriv |
| 03 Sept 2024 | GRANT_AWARD | Nuvation Bio Inc. | 200,801 | 0.00 USD | deriv |
| 14 Jun 2024 | GRANT_AWARD | ARDELYX, INC. | 40,243 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | ARDELYX, INC. | 49,237 | 0.00 USD | deriv |
| 15 May 2023 | GRANT_AWARD | Nuvation Bio Inc. | 366,744 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | ARDELYX, INC. | 100,000 | 0.00 USD | deriv |
| 16 May 2022 | GRANT_AWARD | Nuvation Bio Inc. | 118,784 | 0.00 USD | deriv |
| 29 Oct 2021 | GRANT_AWARD | Nuvation Bio Inc. | 45,229 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | ARDELYX, INC. | 32,765 | 0.00 USD | deriv |
| 30 Mar 2021 | PURCHASE | Nuvation Bio Inc. | 5,000 | 9.98 USD | |
| 25 Mar 2021 | SALE | Epizyme, Inc. | 10,328 | 7.85 USD | |
| 10 Feb 2021 | GRANT_AWARD | Nuvation Bio Inc. | 51,703 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 16 Dec 2025.